Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Cancer Discovery · 02.11.2026 · 16 (11) · 2414-2431
DOI: 10.1158/2159-8290.cd-24-1908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Discovery, online erschienen am 26.06.2026. Verfasst von Haoyue Liu und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas. Hauptthemen laut MEDLINE: Interferons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Stand Up To Cancer (SU2C), Cancer Prevention and Research Institute of Texas (CPRIT).
Abstract (Originalsprache)
Tumor microbes are increasingly recognized for modulating tumor behavior and therapy responses. Intratumoral microbial burden (ITMB) analysis across cancers revealed regulation of immune pathways and activated mast cells, mostly in colorectal and gastric cancers. High-ITMB colorectal cancer leads to interferon (IFN) regulation and is associated with improved outcomes in advanced disease. Single-cell sequencing revealed induction of IFN-related genes (IRG) within microbe-containing human colorectal cancer. Gastrointestinal-luminal mismatch repair–deficient (MMRd) tumors had higher ITMB than proficient tumors. In a rectal MMRd cohort with 100% remission after immune checkpoint blockade (ICB), tumor microbes and microbe-containing mast cells increased. In ICB-sensitive syngeneic murine MMRd tumor models, local tumor microbial depletion impaired ICB efficacy while downregulating IFN signaling. Forced upregulation of IRGs in ADAR1-deficient cancer cells restored immunotherapy responses during microbial ablation. These data highlight dynamic interplay among ITMB, host defense, and immunogenicity, which seems key to determine therapy responses. Significance: The ITMB is linked to transcriptional and immune functional changes that seem to determine tumor sensitivity to immunotherapy. These findings highlight the key role of tumor-resident microbes in shaping the tumor ecosystem, which could be targeted to modulate therapy responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Tumor Ecosystems Center, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- College of Pharmacy, Daegu Catholic University, Gyeongsan-si, South Korea.
- Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
ORCID-Profile: Haoyue Liu, Jeong-Hoon Jang, Fuduan Peng, Hajar Rajaei, Vidhi Chandra, Le Li, Dhwani N Rupani, Sedigheh Taghinezhadsaroukalaei, Yuehui Zhao, Erika Y Faraoni, Thais F Bartelli, Olivereen Le Roux, Virginia Tahan, Fernando Jimenez-Arancon, Seyda Baydogan, Amir Hossein Mohseni, Javier A Gomez, Mitesh Patel, Jared K Burks, Barbara Miño Galvez, Daniel E Carvajal-Hausdorf, Erika Ruiz-García, Edith A Fernandez-Figueroa, Scott Kopetz, Steven B Maron, Andrea Cercek, Erick M Riquelme, Nicholas E Navin, James Robert White, Linghua Wang, Luis A Diaz, Florencia McAllister
Förderung
- NCI NIH HHS
- Stand Up To Cancer (SU2C)
- Cancer Prevention and Research Institute of Texas (CPRIT)
- National Cancer Institute (NCI)
- Andrew Sabin Family Foundation
- U.S. Department of Defense (DOD)
- University of Texas MD Anderson Cancer Center (MD Anderson)
Zitieren
APA
Liu, H., Jang, J. H., Peng, F., Rajaei, H., Chandra, V., Li, L., Rupani, D. N., Taghinezhadsaroukalaei, S., Zhao, Y., Faraoni, E. Y., Bartelli, T. F., Le Roux, O., Tahan, V., Jimenez-Arancon, F., Baydogan, S., Mohseni, A. H., Gomez, J. A., Patel, M., Burks, J. K., …, & McAllister, F. (2026). Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling. Cancer Discovery, 16(11), 2414-2431. https://doi.org/10.1158/2159-8290.cd-24-1908
Vancouver
Liu H, Jang JH, Peng F, Rajaei H, Chandra V, Li L, et al. Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling. Cancer Discovery. 2026;16(11):2414-2431. doi:10.1158/2159-8290.cd-24-1908
BibTeX
@article{Liu2026,
author = {Liu, Haoyue and Jang, Jeong-Hoon and Peng, Fuduan and Rajaei, Hajar and Chandra, Vidhi and Li, Le and Rupani, Dhwani N and Taghinezhadsaroukalaei, Sedigheh and Zhao, Yuehui and Faraoni, Erika Y and Bartelli, Thais F and Le Roux, Olivereen and Tahan, Virginia and Jimenez-Arancon, Fernando and Baydogan, Seyda and Mohseni, Amir Hossein and Gomez, Javier A and Patel, Mitesh and Burks, Jared K and Miño Galvez, Barbara and Carvajal-Hausdorf, Daniel E and Ruiz-García, Erika and Fernandez-Figueroa, Edith A and Kopetz, Scott and Maron, Steven B and Cercek, Andrea and Riquelme, Erick M and Navin, Nicholas E and White, James Robert and Wang, Linghua and Diaz, Luis A and McAllister, Florencia},
title = {Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling},
journal = {Cancer Discovery},
year = {2026},
volume = {16},
number = {11},
pages = {2414--2431},
doi = {10.1158/2159-8290.cd-24-1908}
}
EUVIMED